Stock Radar: Breakout from falling trendline makes Glenmark an attractive buy; check target & stop loss

Glenmark Pharma Ltd has broken out of an 8-month consolidation, breaching a downward trendline. Experts suggest a buy for short-to-medium term traders, targeting Rs 1,940 in 2-4 months. The stock's recent rally, coupled with positive technical indicators and sector outperformance, indicates further upside potential, according to Religare Broking Ltd.